Gefitinib in non-small cell lung cancer

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.6, 2005-06, pp. : 985-993

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of gefitinib in the management of Asian patients with non-small cell lung cancer

By Chang Alex Y

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 401-411

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Gefitinib in Non-Small-Cell Lung Cancer

By Frampton James E. Easthope Stephanie E.

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 133-136

Adis International

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Gefitinib: Interstitial pneumonia in a patient with non-small cell lung cancer: case report

Reactions Weekly, Vol. 1, Iss. 1057, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Gefitinib: A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer

By Sanford Mark Scott Lesley J.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2303-2328

Adis International

Access to resources Recommend Favorite